We use cookies to customise content for your subscription and for analytics. If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.
The award of £17.5 million damages to Apotex under a cross-undertaking in damages given by Servier has been set aside by the High Court on the basis of public policy and the rule of law that no action can arise from an illegal or immoral act here the manufacture of a generic medicine that infringed a valid foreign patent
